Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
3,235
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease

Ying JiangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Xuemei ZhangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; ;State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, Shandong Province, PR ChinaView further author information
,
Hongjie MuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Hongchen HuaSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Dongyu DuanSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Xiuju YanSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Yiyun WangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Qingqing MengSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Xiaoyan LuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; View further author information
,
Aiping WangSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; Correspondence[email protected] [email protected]
View further author information
,
Wanhui LiuSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; ;State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, Shandong Province, PR ChinaView further author information
,
Youxin LiSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; ;State Key Laboratory of Long-Acting and Targeting Drug Delivery System, Shandong Luye Pharmaceutical Co., Ltd, Yantai, Shandong Province, PR ChinaView further author information
&
Kaoxiang SunSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, Shandong Province, PR China; Correspondence[email protected] [email protected]
View further author information
 show all
Pages 143-152 | Received 26 Oct 2017, Accepted 17 Dec 2017, Published online: 23 Dec 2017

Related Research Data

Pharmacological Treatment of Parkinson Disease
Source: American Medical Association (AMA)
N-methyl pyrrolidone/bone morphogenetic protein-2 double delivery with in situ forming implants
Source: Elsevier BV
Exenatide-loaded microsphere/thermosensitive hydrogel long-acting delivery system with high drug bioactivity
Source: Elsevier BV
An effective novel delivery strategy of rasagiline for Parkinson's disease
Source: Elsevier BV
Validated LC–MS/MS method for quantitative determination of rasagiline in human plasma and its application to a pharmacokinetic study
Source: Elsevier BV
Design of Experiments
Source: Springer Berlin Heidelberg
Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye
Source: Elsevier BV
Simultaneous bioanalysis of rasagiline and its major metabolites in human plasma by LC–MS/MS: Application to a clinical pharmacokinetic study
Source: Elsevier BV
Current approaches to the treatment of Parkinson’s Disease
Source: Elsevier BV
Development and validation of a reverse phase liquid chromatography method for the quantification of rasagiline mesylate in biodegradable PLGA microspheres
Source: Elsevier BV
Solvent induced phase inversion-based in situ forming controlled release drug delivery implants
Source: Elsevier BV
Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
Source: Elsevier BV
In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm
Source: Elsevier BV
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
Source: The Lancet Publishing Group
Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice
Source: Elsevier BV
Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease
Source: Taylor & Francis
A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release
Source: Springer Nature
Novel nanohybrid biocatalyst: application in the kinetic resolution of secondary alcohols
Source: Springer Science and Business Media LLC
Rhodium‐Catalyzed Cascade Radical Cyclization of 1,6‐Enynes with Br−CX 3 : Access to Bromine‐Containing Trihalomethylated Pyrrolidines
Source: Wiley
Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Source: Elsevier BV
Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism
Source: Elsevier BV
Nasalin-situgels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization
Source: Informa UK Limited
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Source: Elsevier BV
Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems
Source: Elsevier BV
Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease
Source: Taylor & Francis
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease
Source: Elsevier BV
Novel microencapsulation of potential drugs with low molecular weight and high hydrophilicity: Hydrogen peroxide as a candidate compound
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.